These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 21342354

  • 1. No effect of fluticasone propionate on linear growth in preschool children with asthma.
    Stefanovic IM, Verona E, Cicak B, Vrsalovic R.
    Pediatr Int; 2011 Oct; 53(5):672-676. PubMed ID: 21342354
    [Abstract] [Full Text] [Related]

  • 2. Effects of nebulized corticosteroids therapy on hypothalamic-pituitary-adrenal axis in young children with recurrent or persistent wheeze.
    Cetinkaya F, Kayiran P, Memioglu N, Tarim OF, Eren N, Erdem E.
    Pediatr Allergy Immunol; 2008 Dec; 19(8):773-6. PubMed ID: 18221460
    [Abstract] [Full Text] [Related]

  • 3. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids.
    Kannisto S, Korppi M, Remes K, Voutilainen R.
    J Clin Endocrinol Metab; 2000 Feb; 85(2):652-7. PubMed ID: 10690871
    [Abstract] [Full Text] [Related]

  • 4. Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma.
    Sorkness CA, LaForce C, Storms W, Lincourt WR, Edwards L, Rogenes PR.
    Clin Ther; 1999 Feb; 21(2):353-67. PubMed ID: 10211538
    [Abstract] [Full Text] [Related]

  • 5. A longitudinal assessment of the effect of inhaled fluticasone propionate therapy on adrenal function and growth in young children with asthma.
    Iles R, Williams RM, Deeb A, Ross-Russell R, Acerini CL.
    Pediatr Pulmonol; 2008 Apr; 43(4):354-9. PubMed ID: 18286548
    [Abstract] [Full Text] [Related]

  • 6. Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function.
    Lee DK, Bates CE, Currie GP, Cowan LM, McFarlane LC, Lipworth BJ.
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):253-8. PubMed ID: 15478385
    [Abstract] [Full Text] [Related]

  • 7. Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma.
    Lipworth BJ, Kaliner MA, LaForce CF, Baker JW, Kaiser HB, Amin D, Kundu S, Williams JE, Engelstaetter R, Banerji DD.
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):465-72. PubMed ID: 15875528
    [Abstract] [Full Text] [Related]

  • 8. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part II. Safety aspects of therapy with fluticasone propionate in asthmatic children].
    Bartkowiak-Emeryk M, Breborowicz A, Emeryk A, Kulus M, Kurzawa R, Lis G, Mazurek H, Niedziela M.
    Pol Merkur Lekarski; 2004 Apr; 17 Suppl 2():11-8. PubMed ID: 15688664
    [Abstract] [Full Text] [Related]

  • 9. Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma.
    Szefler S, Rohatagi S, Williams J, Lloyd M, Kundu S, Banerji D.
    Chest; 2005 Sep; 128(3):1104-14. PubMed ID: 16162694
    [Abstract] [Full Text] [Related]

  • 10. Fluticasone propionate in children with moderate asthma.
    Hoekstra MO, Grol MH, Bouman K, Stijnen T, Köeter GH, Kauffman HF, Gerritsen J.
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1039-44. PubMed ID: 8887604
    [Abstract] [Full Text] [Related]

  • 11. Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing.
    Bisgaard H, Allen DB, Milanowski J, Kalev I, Willits L, Davies P.
    Pediatrics; 2004 Feb; 113(2):e87-94. PubMed ID: 14754977
    [Abstract] [Full Text] [Related]

  • 12. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [Abstract] [Full Text] [Related]

  • 13. Hypothalamic-pituitary-adrenal axis suppression in asthmatic school children.
    Zöllner EW, Lombard CJ, Galal U, Hough FS, Irusen EM, Weinberg E.
    Pediatrics; 2012 Dec; 130(6):e1512-9. PubMed ID: 23147980
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of adrenocortical function in 3-7 aged asthmatic children treated with moderate doses of fluticasone propionate: reliability of dehydroepiandrosterone sulphate (dhea-s) as a screening test.
    Sahiner UM, Cetinkaya S, Ozmen S, Arslan Z.
    Allergol Immunopathol (Madr); 2011 Dec; 39(3):154-8. PubMed ID: 21257254
    [Abstract] [Full Text] [Related]

  • 15. Safety of inhaled fluticasone propionate therapy for pediatric asthma - a systematic review.
    Muley P, Shah M, Muley A.
    Curr Drug Saf; 2013 Jul; 8(3):186-94. PubMed ID: 23859431
    [Abstract] [Full Text] [Related]

  • 16. Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled and nasal corticosteroids: is the early-morning serum adrenocorticotropic hormone (ACTH) a useful screening test?
    Zöllner EW, Lombard C, Galal U, Hough S, Irusen E, Weinberg E.
    Pediatr Allergy Immunol; 2011 Sep; 22(6):614-20. PubMed ID: 21797928
    [Abstract] [Full Text] [Related]

  • 17. Hypothalamic-pituitary-adrenal axis effects of mometasone furoate/formoterol fumarate vs fluticasone propionate/salmeterol administered through metered-dose inhaler.
    Kosoglou T, Hubbell J, Cutler DL, Johnson-Levonas AO, Xu D, Kantesaria BS, Kim K, Miller SD.
    Chest; 2013 Dec; 144(6):1795-1802. PubMed ID: 24077095
    [Abstract] [Full Text] [Related]

  • 18. Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma.
    Price JF, Russell G, Hindmarsh PC, Weller P, Heaf DP, Williams J.
    Pediatr Pulmonol; 1997 Sep; 24(3):178-86. PubMed ID: 9330414
    [Abstract] [Full Text] [Related]

  • 19. Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma.
    Li JT, Ford LB, Chervinsky P, Weisberg SC, Kellerman DJ, Faulkner KG, Herje NE, Hamedani A, Harding SM, Shah T.
    J Allergy Clin Immunol; 1999 Jun; 103(6):1062-8. PubMed ID: 10359887
    [Abstract] [Full Text] [Related]

  • 20. Potential effects of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial.
    Kemp JP, Osur S, Shrewsbury SB, Herje NE, Duke SP, Harding SM, Faulkner K, Crim CC.
    Mayo Clin Proc; 2004 Apr; 79(4):458-66. PubMed ID: 15065610
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.